Panakeia
Panakeia is an AI-driven company that provides multi-omics molecular analysis of patient tissues from routine tissue images, significantly faster and cheaper than traditional methods. Their AI technology extracts biomarker information directly from H&E-stained tissue images, offering reliable results in minutes instead of days or weeks. Panakeia's offerings enhance both clinical diagnostics and drug development. Their product portfolio includes PANProfiler Breast for breast cancer diagnostics, which analyzes H&E slides to report ER, PR, HER2 status, integrating seamlessly with existing digital workflows and reducing the need for lab tests. They also provide an AI platform for research and drug development, enabling multi-omics profiling and biomarker discovery from histopathology. Panakeia's mission is to make precision diagnostics instrument-free and accessible globally.
Panakeia
Panakeia is an AI-driven company that provides multi-omics molecular analysis of patient tissues from routine tissue images, significantly faster and cheaper than traditional methods. Their AI technology extracts biomarker information directly from H&E-stained tissue images, offering reliable results in minutes instead of days or weeks. Panakeia's offerings enhance both clinical diagnostics and drug development. Their product portfolio includes PANProfiler Breast for breast cancer diagnostics, which analyzes H&E slides to report ER, PR, HER2 status, integrating seamlessly with existing digital workflows and reducing the need for lab tests. They also provide an AI platform for research and drug development, enabling multi-omics profiling and biomarker discovery from histopathology. Panakeia's mission is to make precision diagnostics instrument-free and accessible globally.
TL;DR
What they do: AI extracts multi-omics biomarker information from routine H&E tissue images
Flagship product: PANProfiler platform (clinical and research products including PANProfiler Breast and PANProfiler Colon)
Founded / HQ: Founded 2018; Cambridge, UK
Funding signal: Multiple funding rounds; latest non-equity assistance on 2024-09-27
Related Companies
| Company |
|---|
 |
 |
 |
 |
 |
Company Overview
Problem Domain
Pathology diagnostics and biomarker discovery for oncology
Founded
2018
Industry
Biotechnology
Tech Stack
Funding Track Record
Most recent listed round
Investor Signal
“Investors named include Springboard Enterprises and Silicon Roundabout Ventures; other investors listed include Alex Macdonald, Creative Destruction Lab (CDL), DigitalHealth.London Accelerator, Entrepreneurs First”